Delivery Order SPE2DB22D3501-SPE2DB24FTH84

Award Date 10/26/23
Potential Completion Date 11/17/23
Potential Value $24K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product, with a potential value of $8,103.66. The contract has a completion date of March 13, 2024. Amerisourcebergen Drug Corp has also been awarded an Indefinite Delivery Contract (IDC) by DLA to provide a comprehensive range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, for the supply of VYVGART 400 MG/20 ML VIAL 20ML pharmaceutical products. The contract has a potential value of $16,207.28 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this award and serves as a supplier of pharmaceuticals and medical supplies to...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract has a potential value of $8,103.66 and a completion date of March 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $16,767.44 firm fixed-price delivery order is for the supply of 4566813903 VYVGART 400 MG/20 ML VIAL 20ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 22, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $25,585.02, is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product, under a Firm Fixed Price delivery order. The contract has an ultimate completion date of April 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical facilities. The prime contractor is Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order with a potential value of $24,310.92 and a completion date of March 27, 2024....
Amerisourcebergen Drug Corp has received a $7,992.26 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply VYVGART 400 MG/20 ML VIAL 20ML pharmaceutical products. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by December 2023. As a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution services company, Amerisourcebergen Drug Corp regularly provides...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $16,207.28 firm fixed price delivery order is for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) issued by DLA to Amerisourcebergen Drug Corp, with a potential value of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $24,310.92 firm fixed price delivery order is for the pharmaceutical product VYVGART 400 MG/20 ML VIAL 20ML, with a completion date of February 22, 2024. Amerisourcebergen Drug Corp, as a prime contractor, provides a wide range of pharmaceutical products and medical supplies to support military treatment programs and...
This federal contract award, with ID SPE2DB22D3016|SPE2DB24FAPV2, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $16,207.28 firm fixed price delivery order is for the pharmaceutical product VYVGART 400 MG/20 ML VIAL 20ML, with a completion date of April 3, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00, which serves...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FTH84
    Delivery Order

Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $23,976.78 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) for 400 mg/20 ml vials of the pharmaceutical product VYVGART. This delivery order has a completion date of November 17, 2023. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. The company holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for delivering pharmaceuticals and medical materials to DLA Troop Support Medical facilities. This specific delivery order was not designated as a set-aside contract.

Generated 5/3/24, 10:05 AM